Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300199
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,608
Award facts
- Contract value 50% obligated
-
- $3,608.00 Current, with exercised options
- $7,216.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26300199?
HHSN26300199 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on June 11, 2012.
How much is contract HHSN26300199 worth?
The government has obligated $3,608 on HHSN26300199. Its potential value, with all options, is $7,216.
Is contract HHSN26300199 an order under another contract?
Yes. HHSN26300199 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300199 competed?
The extent of competition for HHSN26300199 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award